ATP synthase subunit a (encoded by atpB) forms part of the membrane-embedded F sector, facilitating proton translocation across the bacterial membrane to drive ATP synthesis . In S. epidermidis, this subunit is hypothesized to function similarly to its counterpart in S. aureus, where ATP synthase activity influences biofilm persistence and immune evasion .
ATP synthase subunits in S. epidermidis contribute to biofilm formation, a key virulence factor. Mutations in ATP synthase genes (e.g., atpA) alter host immune responses by modulating bacterial lysis and cytokine production . Subunit a likely plays a role in maintaining proton gradients essential for biofilm matrix stability.
ATP synthase is a target for novel antibiotics like tomatidine (TO), which inhibits subunit c (atpE) . Subunit a’s role in proton transport makes it a potential candidate for similar therapeutic strategies, though no direct inhibitors have been reported.
Heterologous Expression: Subunit a’s transmembrane domains pose challenges for soluble expression, necessitating optimized vectors and host systems .
Functional Assays: ATP hydrolysis and binding studies (e.g., microscale thermophoresis) could validate interactions with protonophores or inhibitors .
Structural Characterization: Cryo-EM or crystallography of S. epidermidis ATP synthase could resolve subunit a’s role in proton channel architecture.
Therapeutic Development: Targeting subunit a may disrupt energy metabolism in antibiotic-resistant strains, akin to strategies explored in S. aureus .
KEGG: ser:SERP1715
STRING: 176279.SERP1715
ATP synthase in S. epidermidis, like in other bacteria, is a multi-subunit enzyme complex that produces ATP from ADP in the presence of a proton gradient across the membrane. The complex consists of two main domains: F₁ (containing the catalytic core) and F₀ (containing the membrane proton channel). These domains are linked by a central stalk and a peripheral stalk . The enzyme harnesses the energy of the proton motive force generated by the respiratory chain to synthesize ATP through a rotary mechanism, with proton translocation coupled to ATP synthesis in the catalytic domain .
In staphylococcal species, ATP synthase plays crucial roles beyond energy production, including influencing biofilm formation and host immune responses. Research on S. aureus has shown that ATP synthase is critical for energy production, homeostasis, and maintaining the proton motive force .
There is often confusion in the literature regarding bacterial ATP synthase nomenclature. In bacterial systems:
The gene atpB typically encodes the a-subunit of the F₀ portion (membrane-embedded sector)
The beta subunit of the F₁ portion (catalytic sector) is typically encoded by atpD in bacteria
In human/mammalian systems, ATP5F1B or ATP5B refers to the beta subunit
This nomenclature inconsistency between bacterial and eukaryotic systems often creates confusion. The beta subunit has an approximate mass of 52 kDa and is an essential component of the ATP synthase complex . When working with recombinant S. epidermidis ATP synthase components, it's critical to clarify exactly which subunit is being referenced.
For recombinant expression of S. epidermidis ATP synthase subunits, researchers can utilize several approaches:
Surrogate Host Expression: Similar to the approach used for Embp protein studies, expression in a non-adhesive surrogate host like S. carnosus TM300 can be advantageous for studying protein interactions without interference from other surface proteins . This approach involves:
Cloning the target ATP synthase gene into an expression vector with an inducible promoter (e.g., tetracycline-inducible system)
Transforming the construct into S. carnosus
Inducing expression with an appropriate inducer (e.g., anhydrotetracycline at 200 ng/ml)
Confirming expression through Western blotting or other detection methods
E. coli Expression Systems: For high-yield production:
Optimize codon usage for E. coli
Use tags (His6, GST) for simplified purification
Express in BL21(DE3) or similar strains optimized for recombinant protein expression
Use auto-induction media or IPTG induction protocols
Cell-Free Expression Systems: For proteins difficult to express in cellular systems due to toxicity or other issues
Purification of recombinant ATP synthase subunits typically employs a multi-step approach:
Affinity Chromatography:
For His-tagged constructs: Ni-NTA or TALON resin
For GST-tagged constructs: Glutathione Sepharose
Ion Exchange Chromatography:
Based on the theoretical isoelectric point of the subunit
Typically anion exchange (Q Sepharose) for ATP synthase subunits
Size Exclusion Chromatography:
Final polishing step
Separates monomeric from aggregated protein
Allows buffer exchange into storage conditions
Specialized Techniques for Membrane Proteins:
Detergent screening (DDM, LDAO, Triton X-100)
Nanodiscs or liposome reconstitution for F₀ subunits
Researchers should validate purified protein using Western blot with specific antibodies , mass spectrometry, and activity assays to ensure both purity and proper folding.
Based on studies in S. aureus and general bacterial pathogenesis principles:
Immune Modulation:
S. aureus ATP synthase influences myeloid-derived suppressor cell (MDSC) and macrophage (MΦ) activation
An S. aureus ΔatpA mutant elicited significantly higher levels of proinflammatory cytokines (IL-12p70, TNF-α, IL-6) from immune cells compared to wild-type
This suggests functional ATP synthase may help suppress proinflammatory responses, facilitating bacterial persistence
Resistance to Immune Killing:
Energy for Virulence Factor Production:
ATP synthase provides energy required for production of virulence factors
In S. epidermidis, this includes factors required for biofilm formation, which is a major virulence mechanism
Methodological approaches to investigate these aspects include:
Co-culture experiments with human immune cells and S. epidermidis wild-type vs. ATP synthase mutants
Animal infection models comparing wild-type and mutant strains
Analysis of virulence factor production in ATP synthase mutants
Structural studies of S. epidermidis ATP synthase can provide valuable insights for antimicrobial development:
Target-Based Drug Design:
High-resolution structures (obtained through X-ray crystallography or cryo-EM) can identify unique features of bacterial ATP synthase compared to human counterparts
Molecular docking studies can identify potential binding sites for inhibitors
Structure-activity relationship studies can guide optimization of lead compounds
Investigation of Species-Specific Features:
Comparison of S. epidermidis ATP synthase with other bacterial species can identify unique structural features
These unique features could be targeted for species-selective inhibition
Methodological Approaches:
Recombinant expression and purification of individual subunits or subcomplexes
Protein crystallization trials with various conditions and additives
Cryo-electron microscopy of the intact complex
NMR studies of smaller subunits or domains
Computational modeling and molecular dynamics simulations
Several experimental approaches can investigate the relationship between ATP synthase function and antibiotic resistance in S. epidermidis:
For studying ATP synthase in biofilm contexts, researchers should consider:
In Vitro Biofilm Models:
Static biofilm assays in microtiter plates
Flow cell systems to mimic dynamic conditions
Confocal microscopy with fluorescent probes for ATP or membrane potential
Ex Vivo Models:
Biofilm formation on medical device materials
Human tissue explant models
In Vivo Models:
Advanced Analytical Techniques:
Single-cell analysis of ATP levels within biofilms
Spatial transcriptomics to map gene expression across biofilm regions
Live-cell imaging with ATP biosensors
Functional Measurements:
Real-time measurements of ATP production within biofilms
Membrane potential assessments in biofilm bacteria
Researchers have several options for detection of S. epidermidis ATP synthase components:
Commercial Antibodies:
Custom Antibody Development:
Production of polyclonal antibodies against recombinant S. epidermidis ATP synthase subunits
Identification of species-specific epitopes for targeted antibody development
Alternative Detection Methods:
FLAG, His, or other epitope tags for recombinant protein detection
Mass spectrometry-based approaches for unbiased detection
Activity-based probes that bind to functional ATP synthase
For functional studies, researchers should consider:
Homologous Expression Systems:
Heterologous Expression in Related Species:
Membrane Protein Expression Systems:
Specialized E. coli strains designed for membrane protein expression
Cell-free expression systems with supplied lipids or detergents
Reconstitution Approaches:
Expression and purification of individual subunits followed by reconstitution
Liposome reconstitution for functional studies of intact complex
Researchers face several challenges:
Membrane Protein Complexity:
ATP synthase is a large, multi-subunit membrane protein complex
Solution: Use detergent screening, nanodiscs, or native membrane vesicles for functional studies
Limited S. epidermidis-Specific Research:
Most detailed ATP synthase studies are from model organisms or S. aureus
Solution: Develop S. epidermidis-specific genetic tools and antibodies
Biofilm Heterogeneity:
Bacteria in different regions of biofilms may have varying ATP synthase expression/activity
Solution: Single-cell approaches and spatial transcriptomics/proteomics
Physiological Relevance:
In vitro conditions may not reflect in vivo ATP synthase function
Solution: Develop more physiologically relevant models incorporating host factors
Understanding S. epidermidis ATP synthase could advance treatment strategies through:
Novel Antimicrobial Targets:
Identifying unique features of bacterial ATP synthase for selective inhibition
Developing compounds that target ATP synthase function specifically in biofilm contexts
Biofilm Disruption Strategies:
Immune Response Modulation:
Diagnostic Applications:
Development of ATP synthase-targeted imaging probes for biofilm detection
Biomarkers based on ATP synthase components or activity
This question could be addressed through:
Strain Collection Analysis:
Sequence analysis of ATP synthase genes across clinical and commensal isolates
Correlation of sequence variations with virulence traits or clinical outcomes
Isogenic Mutant Construction:
Generation of point mutations in key ATP synthase residues
Assessment of resulting changes in fitness, virulence, and biofilm formation
Competition Assays:
In vitro and in vivo competition between wild-type and ATP synthase mutants
Determination of fitness costs associated with ATP synthase variations
Transcriptional Analysis:
Compare transcriptional responses to environmental stresses between strains
Identify compensatory mechanisms in strains with ATP synthase variations